Vai al contenuto principale
Logo Università
Logo di Department of Molecular Biotechnology and Health Sciences

Department of Molecular Biotechnology and Health Sciences

Department of Molecular Biotechnology and Health Sciences

Follow us

Logo di Department of Molecular Biotechnology and Health Sciences
  • Home
  • Cavallo Bibliography

Bibliography (last 5 years):

  1. Riccardo F, Bolli E, Macagno M, Arigoni M, Cavallo F, Quaglino E. Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. Curr Top Microbiol Immunol. 2014 Oct 8.
  2. Magnetto C, Prato M, Khadjavi A, Giribaldi G, Fenoglio I, Jose J, Gulino GR, Cavallo F, Quaglino E, Benintende E, Varetto G, Troia A, Cavalli R, Guiot C. Ultrasound-activated decafluoropentane-cored and chitosan-shelled nanodroplets for oxygen delivery to hypoxic cutaneous tissues. RSC Adv, 2014;4(72):38433-41.
  3. Fornari C, Beccuti M, Lanzardo S, Conti L, Balbo G, Cavallo F, Calogero RA, Cordero F. A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. PLoS One. 2014 Sep 3;9(9):e106193..
  4. Cavallo F, Aurisicchio L, Mancini R, Ciliberto G. Xenogene vaccination in the therapy of cancer. Expert Opin Biol Ther. 2014, 15:1-16.
  5. Riccardo F, Iussich S, Maniscalco L, Lorda Mayayo S, La Rosa G, Arigoni M, De Maria R, Gattino F, Lanzardo S, Lardone E, Martano M, Morello E, Prestigio S, Fiore A, Quaglino E, Zabarino S, Ferrone S, Buracco P, Cavallo F. CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clinical Cancer Res 2014 Jul 15;20(14):3753-62.
  6. Conti L, Ruiu R, Barutello G, Macagno M, Bandini S, Cavallo F, Lanzardo S. Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice. BioMed Research International, Article ID 534969, 16 pages, 2014. doi:10.1155/2014/534969
  7. Masuelli L, Fantini M, Benvenuto M, Sacchetti P, Giganti MG, Tresoldi I, Lido P, Lista F, Cavallo F, Nanni P, Schlom J, Modesti A, Bei R. Intratumoral delivery of recombinant vaccinia virus encoding for erbb2/neu inhibits the growth of salivary gland carcinoma cells. J Transl Med 2014, 12:122.
  8. Riccardo F, Arigoni M, Buson G, Zago E, Iezzi M, Longo DL, Carrara M, Fiore A, Nuzzo S, Bicciato S, Nanni P, Landuzzi L, Cavallo F, Calogero RA, Quaglino E. Characterization of a genetic mouse model of lung cancer: a promise to identify non-small cell lung cancer therapeutic targets and biomarkers. BMC Genomics 2014, 15(Suppl 3):S1.
  9. Macagno M, Bandini S, Stramucci L, Quaglino E, Conti L, Balmas E, Smyth MJ, Lollini PL, Musiani P, Forni G, Iezzi M, Cavallo F. Multiple roles of perforin in hampering ErbB-2 (Her-2/neu) carcinogenesis in transgenic male mice. J Immunol 2014, 192(11):5434-41.
  10. Occhipinti S, Sponton L, Rolla S, Caorsi C, Novarino A, Donadio M, Bustreo S, Satolli MA, Pecchioni C, Marchini C, Amici A, Cavallo F, Cappello P, Pierobon D, Novelli F, Giovarelli M. Chimeric Rat/Human HER2 efficiently circumvents HER2 tolerance in cancer patients. Clinical Cancer Res 2014, 20(11):2910-21.
  11. Bolli E, Conti L, Riccardo F, Marchini C, Amici A, Cavallo F, Quaglino E. Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9-11, 2013. Cancer Immunol Immunother. 2014, 63(5):529-33.
  12. De Giovanni C, Nicoletti G, Quaglino E, Landuzzi L, Palladini A, Ianzano ML, Dall Ora M, Grosso V, Ranieri D, Laranga R, Croci S, Amici A, Penichet ML, Iezzi M, Cavallo F, Nanni P, Lollini PL. Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. Breast Cancer Res. 2014 Jan 23;16(1):R10
  13. Dentelli P, Cavallo F, Brizzi MF. Membrane-bound KIT ligand-targeting DNA vaccination inhibits mammary tumor growth. OncoImmunology 2014 Jan 1;3(1):e27259.
  14. Ross JA, Spadaro M, Rosado DC, Cavallo F, Kirken RA, Pericle F. Inhibition of JAK3 with a novel, selective, and orally active small molecule induces therapeutic response in preclinical models of T-cell malignancy. Leukemia 2013, 28(4):941-4.
  15. Olgasi C, Dentelli P, Rosso A, Iavello A, Togliatto G, Toto V, Liberatore M, Barutello G, Musiani P, Cavallo F, and Brizzi MF. DNA vaccination against mbKitL: a new approach to inhibiting tumor growth and angiogenesis. Eur J Cancer 2014 Jan;50(1):234-46.
  16. Spadaro M, Montone M, Arigoni M, Cantarella D, Forni G, Pericle F, Pascolo S, Calogero RA, Cavallo F. Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors-2 and -4. FASEB J. 2014 Jan;28(1):416-29.
  17. Lollini PL, Cavallo F, De Giovanni C, Nanni P.  Preclinical vaccines against mammary carcinoma. Expert Rev. Vaccines 2013 Dec;12(12):1449-63.
  18. Bandini S, Curcio C, Macagno M, Quaglino E, Arigoni M, Lanzardo S, Hysi A, Barutello G, Consolino L, Longo D, Musiani P, Forni G, Iezzi M, Cavallo F. Early onset and enhanced growth of autochthonous mammary carcinomas in C3 deficient Her2/neu transgenic mice. OncoImmunology 2013; 2:e26137
  19. Conti L, Lanzardo S, Arigoni M, Antonazzo R, Radaelli E, Cantarella D, Calogero RA, Cavallo F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. FASEB J. 2013 Dec;27(12):4731-44.
  20. Cordero F, Beccuti M, Fornari C, Lanzardo S, Conti L, Cavallo F, Balbo G, Calogero R. Multi-level model for the investigation of oncoantigen-driven vaccination effect. BMC Bioinformatics. 2013;14 Suppl 6:S11.
  21. Carrara M, Beccuti M, Cavallo F, Donatelli S, Lazzarato F, Cordero F, Calogero RA. State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? BMC Bioinformatics. 2013 Apr 22;14 Suppl 7:S2.
  22. Marchini C, Kalogris C, Garulli C, Pietrella L, Gabrielli F, Curcio C, Quaglino E, Cavallo F, Amici A. Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers. Front Oncol. 2013 May 14;3:122
  23. Arigoni M, Barutello G, Riccardo F, Ercole E, Cantarella D, Orso F, Conti L, Lanzardo S, Taverna D, Merighi I, Calogero RA, Cavallo F, Quaglino E. miR-135b Coordinates Progression of ErbB2-Driven Mammary Carcinomas through Suppression of MID1 and MTCH2. Am J Pathol. 2013 Jun;182(6):2058-70.
  24. Carrara M, Beccuti M, Lazzarato F, Cavallo F, Cordero F, Donatelli S, Calogero RA. State-of-the-art fusion-finder algorithms sensitivity and specificity. Biomed Res Int. 2013; 2013:340620.
  25. Conti L, Lanzardo S, Iezzi M, Montone M, Bolli E, Brioschi C, Maiocchi A., Forni G, Cavallo F. Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe binding αvβ3 integrins. Contrast Media Mol Imaging. 2013 Jul-Aug;8(4):350-60.
  26. Ronchi G, Gambarotta G, Di Scipio F, Slamone P, Sprio AE, Cavallo F, Perroteau I, Berta GN, Geuna S. ErbB2 receptor over-expression improves post-traumatic peripheral nerve regeneration in adult mice. PLoS One. 2013;8(2):e56282.
  27. Cappello P, Rolla S, Chiarle R, Principe M, Cavallo F, Perconti G, Feo S, Giovarelli M, Novelli F. Vaccination with ENO1-DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastoenteroly. 2013 May;144(5):1098-106.
  28. Iezzi M, Calogero RA, Spadaro M, Musiani P, Forni G, Cavallo F. BALB-neuT female mice as a dynamic model of mammary cancer.  In: Xinkang Wang. Translational Animal Models in Drug Discovery and Development. 2012; p. 139-166, Bentham Science Publisher.
  29. Iezzi M, Quaglino E, Amici A, Lollini PL, Forni G, Cavallo F. DNA vaccination against oncoantigens: A promise. Oncoimmunology. 2012 May 1;1(3):316-325.
  30. Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C, Iezzi M, Zheng Y, Barkefors I, Holmgren L, Cavallo F. A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis. 2012;15(2):305-16.
  31. Burkhardt UE, Sloots A, Jakobi V, Wei WZ, Cavallo F, Kloke BP, Wels WS. IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells. Cancer Immunol Immunother. 2012;61(9):1473-84
  32. Quaglino E, Riccardo F, Macagno M, Bandini S, Cojoca R, Ercole E,  Amici A, Cavallo F. Chimeric DNA vaccines against ErbB2+ Carcinomas: from mice to humans. Cancers. 2011, 3:3225-3241.
  33. Iezzi M, Quaglino E, Cappello P, Toto V, Sabatini F, Curcio C, Garotta G, Musiani P, Cavallo F. HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. Int J Immunopathol Pharmacol. 2011; 24(3):621-30.
  34. Lorda Mayayo S, Prestigio S, Maniscalco L, La Rosa G, Aricò A, De Maria R, Cavallo F, Ferrone S, Buracco P, Iussich S. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma. Vet J. 2011 Nov;190(2):e26-30
  35. Riganti C, Pinto H, Bolli E, Belisario DC, Calogero RA, Bosia A, Cavallo F. Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. Biochem Pharmacol. 2011 Nov 1;82(9):1079-89.
  36. Berta GN, Sprio AE, Iezzi M, Spadaro M, Cappia S, Salamone P, Di Scipio F, Mognetti B, Papotti M, Musiani P, Forni G, Cavallo F.  A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamsters. Cancer Prev Res, 2011, 4(7):994-1001
  37. Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL. 2011: The immune hallmarks of cancer. Cancer Immunol Immunother, 2011, 60(3):319-26
  38. Noris E, Poli A, Cojoca R, Rittà M, Cavallo F, Vaglio S, Matic S, Landolfo S. A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch Virol. 2011, 156(4):587-95.
  39. Lollini PL, Nicoletti G, Landuzzi L, Cavallo F, Forni G, De Giovanni C, Nanni P. Vaccines and Other Immunological Approaches for Cancer Immunoprevention. Curr Drug Targets. 2011, 12:1957-73
  40. Bolli E, Quaglino E, Arigoni M, Lollini PL, Calogero RA, Forni G, Cavallo F. Oncoantigens for an immune prevention of cancer. Am J Cancer Res 2011;1(2):255-264
  41. Triulzi C, Vertuani S, Curcio C, Antognoli A, Seibt J, Akusjärvi G, Wei WZ, Cavallo F, Kiessling R. Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors. Cancer Res. 2010; 70(19):7431-41
  42. Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolò C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F. Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy. J Immunol 2010, 184(11):6124-32
  43. Porzia A, Lanzardo S, Citti A, Cavallo F, Forni G, Santoni A, Galandrini R, Paolini R. Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. J Immunol 2010;184(8):4170-7
  44. Quaglino E, Mastini C, Amici A, Marchini C, Iezzi M, Lanzardo S, De Giovanni C, Montani M,  Lollini PL, Masucci G, Forni G and Cavallo F. A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. Cancer Res. 2010;70(7):2604-12
  45. Barbieri I, Pensa S, Pannellini T, Quaglino E, Maritano D, Demaria M, Voster A, Turkson J, Cavallo F, Watson CJ, Provero P, Musiani P, Poli V. Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten. Cancer Res. 2010 Mar 15;70(6):2558-67
  46. Barbieri I, Quaglino E, Maritano D, Pannellini T, Riera L, Cavallo F, Forni G, Musiani P, Chiarle R, Poli V. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. Mol Carcinog. 2010 Feb;49(2):114-20.
  47. Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, Holen I, Mönkkönen H, Boccadoro M, Forni G, Musiani P, Bosia A, Cavallo F, Massaia M. Zoledronic acid repolarizes tumor-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med. 2010 Dec;14(12):2803-15.
Last update: 21/09/2018 23:32
Location: https://www.dmbhs.unito.it/robots.html
Non cliccare qui!